New acid reflux drugs put to the test against standard treatment

NCT ID NCT06953986

Recruiting now Disease control Sponsor: Asian Institute of Gastroenterology, India Source: ClinicalTrials.gov ↗

Summary

This study aims to see if two different doses of a new medication called vonaprazan work as well as or better than the standard drug esomeprazole for healing severe damage caused by acid reflux in the esophagus. About 414 adults with confirmed, moderate-to-severe reflux damage will take one of the three pills daily for 8 weeks. Doctors will check if the damage has healed using a camera test and see if symptoms like heartburn improve.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asian Institute of Gastroenterology /Aig Hospitals
RECRUITING

Hyderabad, Telangana, 500082, India

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

GERD